These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 19583013)

  • 1. [Fully possible to reduce the costs of hypertension treatment].
    Wettermark B; Angman A; Hjemdahl P
    Lakartidningen; 2009 Jun 3-9; 106(23):1558-62. PubMed ID: 19583013
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting.
    Amira CO; Okubadejo NU
    J Hum Hypertens; 2006 Nov; 20(11):894-7. PubMed ID: 16915299
    [No Abstract]   [Full Text] [Related]  

  • 3. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
    Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Consequences of ALLHAT: Thiazides rehabilitated--time to change prescription patterns].
    Hernborg A; Håkansson J; Werkö L; Berglund G
    Lakartidningen; 2003 Feb; 100(6):408-10. PubMed ID: 12607432
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Stading JA; Stoysich AM; Ryschon K
    Clin Ther; 1994; 16(1):88-102; discussion 87. PubMed ID: 7911403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tax payers have payed billions for the "blood pressure maffia's" actions].
    Järhult B; Lindahl SO
    Lakartidningen; 2003 May; 100(21):1917-8. PubMed ID: 12815880
    [No Abstract]   [Full Text] [Related]  

  • 7. Reducing costs and improving hypertension management.
    Stankus V; Hemmelgarn B; Campbell NR; Chen G; McAlister FA; Tsuyuki RT
    Can J Clin Pharmacol; 2009; 16(1):e151-5. PubMed ID: 19193969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comrades! There must be some blood order in the field of hypertension!].
    Melander A
    Lakartidningen; 2005 Apr 4-10; 102(14):1068-70. PubMed ID: 15892478
    [No Abstract]   [Full Text] [Related]  

  • 9. [German Hypertension League update. What does the ALLHAT Study really mean?].
    MMW Fortschr Med; 2003 Jun; 145(23):45-6. PubMed ID: 12854226
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Following evidence-based prescribing guidelines for antihypertensives could save big bucks.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jun; 15(11):1, 6-7. PubMed ID: 15241883
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antihypertensive pharmacotherapy of patients in primary care with either a statutory or private health insurance].
    Laux G; Szecsenyi J; Miksch A; Grün B; Gutscher A; Grün B; Rosemann T; Kühlein T
    Med Klin (Munich); 2009 Feb; 104(2):108-13. PubMed ID: 19242661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of cost variation in different brands of antihypertensive agents.
    Moharana AK; Khurana S; Lal A
    J Assoc Physicians India; 1998 Jun; 46(6):573-4. PubMed ID: 11273270
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combination therapy in hypertension].
    Tsukiyama H; Shigemasa T; Kobayashi I
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():328-32. PubMed ID: 16981563
    [No Abstract]   [Full Text] [Related]  

  • 15. Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment.
    Wettermark B; Godman B; Neovius M; Hedberg N; Mellgren TO; Kahan T
    Health Policy; 2010 Mar; 94(3):221-9. PubMed ID: 19879009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination therapy of antihypertensive drugs].
    Ruskoaho H
    Duodecim; 1996; 112(13):1205-8. PubMed ID: 10596089
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypertension therapy--never without diuretics?].
    Anlauf M
    MMW Fortschr Med; 2007 Nov; 149(46):31-3. PubMed ID: 18069189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Health care too costly? Saving more than 10 million euros in 2 months!].
    Rappert B
    MMW Fortschr Med; 2003 Nov; 145(47):65. PubMed ID: 14725043
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors influencing the switch in the use of antihypertensive medications.
    Chou CC; Lee MS; Ke CH; Chuang MH
    Int J Clin Pract; 2005 Jan; 59(1):85-91. PubMed ID: 15707471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.